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CD4+ T lymphocytes are key to immunological
memory. Here we show that in the memory phase of
specific immune responses, most of the memory
CD4+ T lymphocytes had relocated into the bone
marrow (BM) within 3–8 weeks after their genera-
tion—a process involving integrin a2. Antigen-
specific memory CD4+ T lymphocytes highly
expressed Ly-6C, unlike most splenic CD44hiCD62L
CD4+ T lymphocytes. In adult mice, more than 80% of
Ly-6ChiCD44hiCD62L memory CD4+ T lymphocytes
were in the BM. In the BM, they associated to IL-7-
expressing VCAM-1+ stroma cells. Gene expression
and proliferation were downregulated, indicating
a resting state. Upon challenge with antigen, they
rapidly expressed cytokines and CD154 and effi-
ciently induced the production of high-affinity anti-
bodies by B lymphocytes. Thus, in the memory phase
of immunity, memory helper T cells are maintained in
BM as resting but highly reactive cells in survival
niches defined by IL-7-expressing stroma cells.
INTRODUCTION
CD4+ T lymphocytes are a key component of immunological
memory. In their absence, the generation of high-affinity memory
B cells and long-lived plasma cells (Gershon and Paul, 1971;
Francus et al., 1991; Crotty et al., 2003) and the maintenance
and secondary expansion of memory CD8+ T lymphocytes
(Shedlock and Shen, 2003; Sun and Bevan, 2003; Janssen
et al., 2003; Sun et al., 2004) are impaired. Despite their eminent
importance for the regulation of immune reactions and immuno-
logical memory, little is known about differentiation, diversity,
and homeostasis of memory CD4+ T cells in body. Memory
CD4+ T cells have an extended lifespan and rapidly respond to
antigen. It is believed that in the absence of antigen, their
numbers are maintained by survival signals and homeostatic
proliferation. Intentionally antigen specific and unintentionally
generated, CD44hiCD62L ‘‘memory-phenotype’’ CD4+ T cells
isolated from secondary lymphoid organs or blood have been
analyzed for signals required for their homeostatic maintenance(Sprent and Surh, 2002; Schluns and Lefrancois, 2003;
Jameson, 2005; Robertson et al., 2006; Ma et al., 2006; Seddon
et al., 2003). IL-15-deficient mice show decreased homeostatic
proliferation of memory CD8+ T cells, but homeostasis of
memory CD4+ T cells is not affected (Lodolce et al., 1998; Ken-
nedy et al., 2000; Goldrath et al., 2002; Becker et al., 2002; Judge
et al., 2002). IL-7 synergizes with IL-15 to support survival and
homeostatic division of memory CD8+ T cells (Tan et al., 2002;
Kieper et al., 2002). IL-7 is considered critical for the mainte-
nance of CD4+ T cell memory, because memory CD4+ T cells
from spleen and lymph nodes (LN), when adoptively transferred
into IL-7-deficient mice, do not persist (Kondrack et al., 2003),
although in IL-7 receptor-deficient mice, CD44hiCD62L CD4+
T cells are still detectable in the spleen (Seddon et al., 2003).
Memory CD8+ T cells and memory plasma cells reside in BM.
After their generation in secondary lymphoid organs, memory
CD8+ T cells preferentially locate to BM for homeostatic mainte-
nance (Becker et al., 2005; Mazo et al., 2005) and they are likely
to obtain IL-15 there, although this has not been formally demon-
strated so far. Memory plasma cells require CXCL12 for survival
and reside next to CXCL12-expressing stroma cells in BM (Slifka
et al., 1995; Manz et al., 1997; Tokoyoda et al., 2004). Newly
generated plasmablasts migrate to BM and there probably
compete with resident plasma cells for habitation of survival
niches provided by CXCL12-expressing cells (Radbruch et al.,
2006). In contrast, memory CD4+ T cells for a long time had
been presumed to constantly circulate the body for surveillance
(Dutton et al., 1998). However, recent studies have suggested
that newly generated memory CD4+ T cells compete with older
ones for hypothetical niches defining the homeostatic pool
(Hataye et al., 2006; Blair and Lefranc¸ois, 2007). So far,
a preferred home tissue of memory CD4+ T cells and their
survival niches has not been identified.
Here we show that in mice, antigen-specific memory CD4+
T cells reside in BM. Within 3–8 weeks after their activation in
secondary lymphoid organs, most antigen-specific CD4+ T
lymphocytes relocated to BM. All of them highly expressed Ly-
6C, whereas few splenic CD4+ T cells expressed this marker.
The tropism for BM was mediated by integrin a2. In BM the
CD4+ T cells resided in contact with IL-7-expressing VCAM-1+
stroma cells and rested in terms of proliferation and gene
expression. Memory CD4+ T cells from BM reacted quickly to
challenge with antigen and provided efficient help to activated
B lymphocytes for the production of high-affinity antibodies.Immunity 30, 721–730, May 22, 2009 ª2009 Elsevier Inc. 721
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Memory CD4+ T Cells Reside in Bone MarrowTheir slow turnover, fast reaction, and efficient helper function
mark Ly-6ChiCD44hiCD62L CD4+ T cells of BM as professional
memory CD4+ T cells, which are maintained in the BM as an
essential component of immunological memory. More than
80% of the CD4+ T cells with this phenotype reside in the BM,
as compared to the rest of the body.
RESULTS
Antigen-Specific Memory CD4+ T Cells Relocate to BM
To define the location of antigen-specific memory CD4+ T cells in
the body with respect to their generation and persistence, we
have analyzed memory CD4+ T cells that had been generated
in intentional immune responses to distinct antigens. First, we
tracked LCMV-specific CD4+CD44hi T cells in the course of
immune responses to LCMV-derived peptide of Smarta T cells
in C57BL/6 mice (Figure 1A). 4 days after immunization,
activated CD4+CD44hi LCMV-specific T cells were present in
spleen and LN but not in BM. From day 28 onward, the number
of CD4+CD44hi T cells in spleen and LN decreased, whereas in
BM their number increased. From day 60 onward, most LCMV-
specific CD4+ T cells resided in BM, more than 80% of total.
They persisted in BM at constant numbers for more than 134
days, which is the period of observation (Figure 1A). In an
immune response to ovalbumin, the antigen-specific memory
CD4+ T cells translocated to BM with similar kinetics, remaining
constant for more than 90 days (Figures S1A and S1B avail-
able online). In the immune response of C57BL/6 mice to KLH
and complete Freund’s adjuvant (CFA), KLH-specific CD4+
T cells, identified according to expression of IFN-g (Figure 1B)
as well as CD154 (Figure 1C; Frentsch et al., 2005) upon restim-
ulation with antigen ex vivo, showed again similar kinetics of
relocation to BM. We conclude that in the memory phase of an
immune response, most antigen-specific CD4+ T cells reside
in the BM.
Ly-6C Is a Marker of Memory CD4+ T Cells
Ly-6C is a marker of memory CD8+ T cells (Walunas et al., 1995).
Here we show that Ly-6C is also a marker of antigen-specific
memory CD4+ T cells. Ly-6C was highly expressed on all
LCMV-specific memory CD4+ T cells in BM 134 days after
immunization (mean fluorescence intensity [MFI], 534 ± 76)
(Figure 2A). Of all CD44hiCD62L CD4+ T cells from BM of unim-
munized mice 40% expressed Ly-6C highly (MFI, 465 ± 35) and
the remaining 60% still expressed Ly-6C, but less of it (MFI, 6.4 ±
0.8) (Figure 2B). Most CD44hiCD62L CD4+ T cells of the spleen
of unimmunized mice expressed little if any Ly-6C (MFI, 0.9 ±
0.5). In the spleen, CD44hiCD62L CD4+ T cells expressing
high amounts of Ly-6C were rare, less than 5% (Figure 2B). Of
all Ly-6ChiCD44hiCD62L CD4+ T cells in normal adult C57BL/6
mice, 80% resided in BM and 20% in spleen, mesenteric LN
(mLN), peripheral LN (pLN; brachial, axillary, and inguinal LN),
thymus, peyer’s patches (PP), blood, and liver (Figure 2C).
CD44hiCD62L CD4+ T cells of BM are residing in the stroma,
not in BM blood, as indicated by the fact that they could not
be mobilized by perfusion (Figure S2). Our results suggest that
Ly-6C is a marker of memory CD4+ T cells in the memory phase
of an immune response.722 Immunity 30, 721–730, May 22, 2009 ª2009 Elsevier Inc.Memory CD4+ T Cells Rest in BM
CD44hiCD62L CD4+ T cells of spleen and BM show no differ-
ence in their expression of well-known cell surface molecules.
Expression of CD3, CD4, CD28, CD44, CD45RB, CD62L,
CXCR4, CXCR5, IL-7Ra, integrin a4, TCR-b, and their TCR Vb
repertoires were comparable (data not shown). For a global
assessment of the differences in gene expression between
CD44hiCD62L CD4+ T cells from spleen and BM, we compared
their transcriptomes. 1756 transcripts were differentially ex-
pressed (Figure 3A). Expression of 96% of these transcripts
was downregulated in BM cells. This shows that Ly-6C+
CD44hiCD62L memory CD4+ T cells from BM are resting as
compared to CD44hiCD62L CD4+ T cells from spleen.
Differential expression of some of the genes identified by mi-
croarray analysis and encoding cell surface proteins was also
analyzed and verified on the level of protein expression of single
cells by immunofluorescence (Figure 3B). Expression of CD24
(HSA), CD93, CD119 (IFN-gR1), CD122 (IL-2Rb), CD186
Figure 1. Memory CD4+ T Cells Reside in BM
(A) Kinetics of tissue distribution of LCMV-specific memory CD4+ T cells in
immunocompetent mice. C57BL/6 mice transferred with 106 CD4+ T cells
from Thy1.1-LCMV-TCR Tg (Smarta) mice were injected with 100 mg of
GP61-80 peptide plus 10 mg LPS. The numbers of the transferred T cells and
their offspring were quantified as Thy1.1+CD4+B220CD44hi T cells in BM
(circles), spleen (diamonds), and mLN (squares) of host mice at 0, 4, 28, 57,
and 134 days. Cell numbers in each tissue are shown as the mean ± SD.
Data are representative of two independent experiments.
(B and C) Kinetics of appearance of KLH-specific memory CD4+ T cells.
C57BL/6 mice were immunized with 100 mg of KLH in CFA and analyzed at
0, 4, 35, and 60 days for KLH-reactive IFN-g+ (B) or CD154+ (C) CD4+CD44hi
T cells in BM (circles) and spleen (diamonds), after stimulation with KLH
ex vivo. Cell numbers in BM and spleen are shown as the mean ± SD. Data
are representative of three independent experiments.
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Memory CD4+ T Cells Reside in Bone Marrow(CXCR6), and CD192 (CCR2) on CD44hiCD62L CD4+ T cells
from BM were higher than on those from spleen.
Also with regard to proliferation, memory CD4+ T cells from
BM were resting. In steady state, less than 0.4% of the cells
were in the S+G2/M phases of the cell cycle, similar to naive
CD4+ T cells (Figures 3C and 3D). Less than 8% synthesized
any DNA, i.e., incorporated 5-bromo-20-deoxyuridine (BrdU),
within 48 hr (Figure S3). These frequencies were 3- to 4-fold
higher for CD44hiCD62L CD4+ T cells from other tissues, indi-
cating that in BM, memory CD4+ T cells are maintained as resting
cells. Taken together, memory CD4+ T cells rest in the BM,
downregulate overall gene expression, and do not proliferate.
Integrin a2 Mediates Homing of Memory
CD4+ T Cells to BM
Another protein differentially expressed by CD44hiCD62L CD4+
T cells from spleen and BM was integrin a2 (Figure 4A). Only 15%
of splenic CD44hiCD62L CD4+ T cells expressed integrin a2
(MFI, 68 ± 15), whereas about 70% of CD44hiCD62L CD4+
T cells from BM expressed integrin a2, and they expressed it
at a higher amount (MFI, 106 ± 25). The preferential homing of
BM CD44hiCD62L CD4+ T cells to BM is dependent on their
expression of integrin a2, as shown by the fact that it can be
Figure 2. Memory CD4+ T Cells Express Ly-6C
(A) Expression of Ly-6C on antigen-specific memory CD4+ T cells. C57BL/6
mice transferred with 106 CD4+ T cells from Thy1.1-LCMV-TCR Tg mice
were injected with 100 mg of GP61-80 peptide plus 10 mg LPS and the expres-
sion of Ly-6C on Thy1.1+CD4+B220CD44hi T cells in BM at 134 days was
analyzed by flow cytometry (bold line; isotype control shows dashed line).
The inserted number shows the MFI. Data are representative of two indepen-
dent experiments.
(B) Expression of Ly-6C on CD44hiCD62L CD4+ T cells of spleen and BM. The
histograms show their expression by CD4+CD44hiCD62LCD25B220
T cells from BM (bold line) and spleen (solid line), and isotype control (dashed
line) and the inserted number shows MFI. Data are representative of four inde-
pendent experiments.
(C) Ly-6ChiCD44hiCD62L CD4+ T cells in various organs. The number of
Ly-6ChiCD44hiCD62LCD25B220 T cells in BM, spleen, mLN, pLN, thymus,
PP, blood, and liver of C57BL/6 mice is shown as the mean + SD of three
independent experiments.blocked by integrin a2-specific antibodies (Figure 4B; Figure S4).
Integrin a2-specific antibodies injected into C57BL/6 mice at day
4, 5, and 6 of an intentional immune reaction to KLH inhibited
relocation of antigen-specific memory CD4+ T cells into BM
(Figure 4C). Integrin a2 is thus an essential mediator for homing
of memory CD4+ T cells into BM.
Memory CD4+ T Cells Reside on IL-7-Expressing
Stroma Niches in BM
Persistence of memory CD4+ T cells is likely to depend on
signal(s) they receive in survival niches (Hataye et al., 2006). In
the BM, about 90% of CD44hiCD62L CD4+ T cells individually
colocalized with VCAM-1+ stroma cells, which also express
IL-7 (Figures 5A and 5B; Tokoyoda et al., 2004), providing
a molecular rationale for the presence of memory CD4+ T cells
in BM (Kondrack et al., 2003). In a specific immune response
to LCMV peptide, more than 95% of the Thy1.1+ LCMV-specific
memory CD4+ T cells colocalized with IL-7-expressing cells of
BM (Figure 5C). The frequency of VCAM-1+ IL-7-expressing
stroma cells in murine BM is about 2%, i.e., a mouse contains
about 5 3 106 IL-7+ BM niches for memory CD4+ T cells.
Because we never observed more than one CD4+ T cell in
contact with one stroma cell, we estimate the capacity of murine
BM for memory CD4+ T cells to be about 53 106 cells. It remains
to be determined to what extent the number of survival niches
indeed determines homeostasis of the memory CD4+ T cell
pool. Memory CD4+ T cells in BM thus rest next to a stroma
cell expressing their mandatory survival factor IL-7.
BM Memory CD4+ T Cells Provide Efficient
and Fast Help to B Cells
Do CD44hiCD62L CD4+ T cells from BM function as profes-
sional helper T cells, in that they provide the signals required
for affinity maturation of the antibodies of activated B cells?
Naive B cells were transferred together with naive or
CD44hiCD62L CD4+ T cells from BM or spleen of unimmunized
mice into lymphopenic mice, which were then immunized with
the T cell-dependent antigen 4-(hydroxy-3-nitro-phenyl) acetyl-
coupled KLH (NP-KLH) and monitored for the appearance and
quality of NP-specific antibodies in serum (Figure 6A). Both
spleen and BM of unimmunized mice contain detectable and
comparable numbers of CD44hiCD62L CD4+ T cells (cross)-
reactive to KLH protein (Figure 1C). As determined by short-
term restimulation ex vivo, about 170 of 5 3 105 cells of total
BM CD44hiCD62L CD4+ T cells (0.034%) and 710 cells of 3 3
106 splenic CD44hiCD62L CD4+ T cells (0.024%) reacted to
KLH by expression of CD154 (Frentsch et al., 2005). In a primary
immune response to NP-KLH, CD44hiCD62L CD4+ T cells from
BM and spleen provided help to the cotransferred B cells for the
production of antigen-specific low-affinity antibodies (anti-NP24
IgM and IgG1), but only CD44
hiCD62L CD4+ T cells from BM
induced the production of high-affinity antibodies (anti-NP3
IgG1), reflecting affinity maturation, a hallmark of T helper cell
function (Figure 6A). The help provided by CD44hiCD62L
CD4+ T cells from BM is antigen specific, because it depended
on the presence of antigen-specific memory T cells (Figure S5).
In a nonlymphopenic C57BL/6 system, memory CD4+ T cells
from BM induced affinity maturation as well (Figures 6B and
6C), both in primary and secondary immune responses, the latterImmunity 30, 721–730, May 22, 2009 ª2009 Elsevier Inc. 723
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Memory CD4+ T Cells Reside in Bone MarrowFigure 3. Gene Expression and Cell Cycle Analysis of Memory CD4+ T Cells from BM or Spleen
(A) Hierarchical cluster analysis of all 1756 differentially expressed genes of CD44hiCD62L CD4+ T cells in BM and spleen. These parameters combined
a threshold for gene expression, Present and Marginal detection, and Decrease or Increase change calls, or a Bonferroni corrected t test p value. Upregulated
genes are shown in red and downregulated genes are in green. The data represent three individual gene arrays for each of the BM and spleen cells.
(B) Expression analysis of selected cell surface molecules. CD4+CD44hiCD62LCD25B220 cells from BM (red) or spleen (green; isotype control shows gray)
were stained with antibodies against CD24, CD93, CD119, CD122, CD186, CD192, CD197, and Ly108 and analyzed by flow cytometry. Data are representative of
two independent cytometric experiments.
(C and D) CD44hiCD25B220 CD4+ T cells from BM, spleen, mLN, and blood and CD44loCD25B220 CD4+ T cells from spleen of C57BL/6 mice were fixed and
their DNA stained with PI. The figures indicate the frequencies of cells with more than 2n of DNA content, i.e., cells in S+G2-M phases (C) and the flow cytometric
analysis (D). Data are shown as mean + SD of two independent experiments.after adoptive transfer of CD44hiCD62L CD4+ T cells from BM
or spleen into C57BL/6 mice. This professional help was depen-
dent on integrin a2, as shown by the fact that it could be blocked
in the primary immune reaction by integrin a2 antibody injected
on days 4, 5, and 6 after immunization (Figure 6B). Moreover,
CD44hiCD62L CD4+ T cells from BM but not spleen of
immunized mice could transfer help for affinity maturation
(Figure 6C). CD44hiCD62L CD4+ T cells from BM contained
about 40% Ly-6Chi and 60% Ly-6Clo cells (Figure 2B). Antigen-
specific memory CD4+ T cells expressed Ly-6C highly
(Figure 2A). Ly-6Chi but not Ly-6Clo CD44hiCD62L CD4+
T cells did provide help for affinity maturation (Figure 6D).
We analyzed whether memory CD4+ T cells from BM are
mobilized when reactivated and leave the BM for the secondary
lymphoid organs. In contrast to the spleen, in BM we could not
detect PNAhi B cells 11 days after immunization (Figure 6E),
indicating that the interaction between memory CD4+ T cells724 Immunity 30, 721–730, May 22, 2009 ª2009 Elsevier Inc.and B cells occurred in secondary lymphoid organs and not in
the BM.
We then examined the molecular basis for the more efficient
help provided by BM memory CD4+ T cells, as compared to
CD44hiCD62L CD4+ T cells from spleen. When activated by
anti-CD3 in vitro, CD44hiCD62L CD4+ T cells from BM strongly
expressed all cytokines of those assayed, at frequencies
higher than those of CD44hiCD62L CD4+ T cells from spleen
(Figure 7A), whereas both CD44hiCD62L CD4+ T cells showed
the same degree of vigorous proliferation and activation-
induced cell death (data not shown). Expression of IFN-g
(Figure 7B) and CD154 (Figure 7C) was rapidly induced in BM
memory CD4+ T cells upon CD3 ligation, like in in vitro-
differentiated effector CD4+ T cells (Lo¨hning et al., 2003),
reaching a peak at 2 to 3 hr. IFN-g- and CD154-expressing
CD44hiCD62L CD4+ T cells from spleen peaked later, at about
4–6 hr, as has been described previously (Figures 7B and 7C;
Immunity
Memory CD4+ T Cells Reside in Bone MarrowFigure 4. Homing of Memory CD4+ T Cells
to the BM
(A) Expression of integrin a2 on CD44hiCD62L
CD4+ T cells of spleen and BM. The histograms
show the expression of integrin a2 by
CD4+CD44hiCD62LCD25B220 T cells from
BM (bold line) and spleen (solid line), and isotype
control (dashed line) and the inserted number
shows MFI. Data are representative of four inde-
pendent experiments.
(B) Homing of CD44hiCD62L CD4+ T cells to the
BM is dependent on integrin a2. 2 3 105 CD4+
CD44hiCD62LCD25 T cells from BM of C57BL/
6 mice were isolated by FACS. Half of the cells
were incubated with Fab fragments of anti-integrin
a2 (filled column) or isotype control (open column),
labeled with CFSE or PKH-26, and together trans-
ferred into RAG1-deficient mice. One day later,
CFSE+ or PKH-26+ CD4+CD44hi T cells were
enumerated in BM and spleen. The value indicates
the frequencies of total numbers of stained cells in each tissue relative to the numbers of transferred cells. Data indicate the mean + SD of three independent
experiments.
(C) Relocation of antigen-specific memory CD4+ T cells to the BM is dependent on integrin a2. At day 4, 5, and 6 after immunization of C57BL/6 mice with 100 mg
of NP-KLH, the mice were injected with 100 mg of Fab fragments of anti-integrin a2 (filled column) or isotype control (open column) and analyzed for KLH-reactive
CD4+CD44hi T cells in BM and spleen at day 10. KLH-reactive cells were enumerated according to expression of CD154 and data indicate the mean + SD of two
independent experiments.Frentsch et al., 2005; Sander et al., 1993). The rapid kinetics
and high frequencies of re-expression of cytokine and the
essential costimulator CD154 qualify BM memory CD4+ T cellsas efficient helpers of B cells. Taken together, our results show
that in the memory phase of immune responses, memory T
helper cells reside in BM as resting cells but can quickly reactFigure 5. Memory CD4+ T Cells Attach to
IL-7+VCAM-1+ Stroma Cells in the BM
(A) Sorted CD4+B220CD62LCD25 T cells from
BM were labeled with CFSE and transferred into
RAG-1-deficient mice, and 16 hr later the location
of CFSE-labeled cells in the host BM was
inspected microscopically. CFSE-labeled cells
next to IL-7+, VCAM-1+, B220+, F4/80hi, Gr-1hi,
or CD11c+ cells were enumerated and are shown
as frequencies of labeled cells in contact with
any such cell types in BM. 150 CD44hiCD62L
CD4+ T cells were counted to determine the
frequency of contacts with IL-7+ cells: 166 for
VCAM-1+, 214 for B220+, 275 for F4/80hi, 212 for
Gr-1hi, 37 for CD11c+ in the transferred bone of
three independent experiments.
(B) The photos show a representative picture of an
IL-7 (blue, left) or F4/80 (red, right) staining versus
CFSE (green).
(C) The photo shows a representative colocaliza-
tion of an IL-7 staining (red) stroma cell versus
a Thy1.1 staining (green) T cell. 78 of 82 Thy1.1+
cells were in contact with an IL-7+ cell.Immunity 30, 721–730, May 22, 2009 ª2009 Elsevier Inc. 725
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Memory CD4+ T Cells Reside in Bone MarrowFigure 6. BM Memory CD4+ T Cells Provide Help for Affinity Maturation of Antibodies In Vivo
(A) Transferred CD44hiCD62L CD4+ T cells from BM provide help for affinity maturation of antibodies in vivo. 43 106 CD19+CD138CD4 cells from spleen were
transferred with 105 CD4+CD44lo(CD62L+)CD25 or CD4+(CD44hi)CD62LCD25 T cells from BM or spleen of C57BL/6 mice, or without T cells, into RAG1-defi-
cient mice. One day later, recipients were immunized with 100 mg NP-KLH in CFA. Blood taken from transferred mice 25 days later was analyzed for anti-NP24-
IgM, anti-NP24-IgG1, and anti-NP3-IgG1 by ELISA. Data are the mean + SD of three independent experiments.
(B) Relocation of antigen-specific CD44hiCD62L CD4+ T cells into the BM is essential to induce affinity maturation of antibodies in normal mice. At day 4, 5, and 6
after immunization of C57BL/6 mice with 100 mg of NP-KLH, mice were injected with 100 mg of Fab fragments of anti-integrin a2, isotype control, or not injected at
all, as indicated. At day 15, blood was taken from immunized mice and analyzed by ELISA. Data indicate the mean + SD of two independent experiments.
(C) Antigen-specific memory CD4+ T cells from BM induce efficient production of high-affinity antibodies upon restimulation. 105 CD4+(CD44hi)CD62LCD25
T cells from BM and spleen of NP-KLH-immunized mice at day 25 were transferred together with 23 106 CD19+CD138CD4 cells from the immunized mice into
naive C57BL/6 mice, followed by injection of NP-KLH. At day 7 after transfer and secondary immunization, the blood of the recipient mice was analyzed by ELISA
for the presence of high-affinity antibodies. Data indicate the mean + SD of three independent experiments.
(D) Ly-6Chi antigen-specific memory CD4+ T cells induce efficient production of high-affinity antibodies. 105 Ly-6Clo or Ly-6Chi CD4+(CD44hi)CD62LCD25
T cells from BM of C57BL/6 mice were transferred together with 4 3 106 CD19+CD138 CD4 cells from C57BL/6 mice, followed by immunization with 100 mg
NP-KLH in CFA. At day 25 after transfer and immunization, blood of recipient mice was analyzed by ELISA for the presence of high-affinity antibodies. Data
indicate the mean + SD of two independent experiments.
(E) Germinal center B cells in BM and spleen. Cells from BM and spleen of unimmunized (open column) or immunized C57BL/6 mice 11 days after immunization
with NP-KLH in CFA (filled column) were stained with PNA and CD19. The value indicates the percentage + SD of PNAhi cells within CD19+ cells. Data are repre-
sentative of two independent experiments. **p < 0.01; ***p < 0.001.to antigenic challenges to provide professional immunological
help (Figure S6).
DISCUSSION
We here show that in the memory phase after an immune
response, more than 80% of the antigen-specific T helper cells
reside in BM. These cells are characterized by expression of
Ly-6C. In BM they persist in stable numbers over long time
periods, resting in terms of gene expression and cell division.
Integrin a2 plays a critical role in the homing process. In
secondary immune reactions, when reactivated, presumably
by surveilling antigen-presenting cells, they provide efficient
and fast help to activated B cells in secondary lymphoid organs.726 Immunity 30, 721–730, May 22, 2009 ª2009 Elsevier Inc.Memory T helper cells are an essential component of the
immunological memory. They control secondary immune reac-
tions and provide critical signals to B cells and cytotoxic
T cells reacting to the same antigen. In order to study the transi-
tion of memory T helper cells from the acute immune reaction to
the memory phase and their persistence in the memory phase,
we have analyzed memory T helper cells generated in defined
immune reactions to distinct antigens. Antigens and adjuvants
were selected to generate immune reactions limited in time
and not persisting, as to allow an unbiased analysis of the
memory phase. In long-lasting immune reactions, e.g., those
provoked by virus or antigen combined with adjuvants like
alum or Freund’s adjuvant, CD44hiCD62L ‘‘memory pheno-
type’’ T helper cells are found in the spleen and LN over long
Immunity
Memory CD4+ T Cells Reside in Bone MarrowFigure 7. BMMemory CD4+ T Cells Express
Cytokines Fast and at High Frequencies
(A) Cytokine expression of CD44hiCD62L CD4+
T cells from BM and spleen ex vivo. CD4+
CD44hiCD62LB220 T cells from BM (filled
column) or spleen (open column) from C57BL/6
mice were isolated, stimulated with plate-bound
anti-CD3 in the presence of Brefeldin A for 5 hr,
fixed, and stained with antibodies for the intracel-
lular cytokines indicated. Data (mean + SD) are
representative of two independent experiments.
(B) Kinetics of cytokine expression by
CD44hiCD62L CD4+ T cells ex vivo. CD4+CD44hi
CD62LB220 T cells from BM (circles) or spleen
(diamonds) from C57BL/6 mice were isolated
and stimulated with plate-bound anti-CD3 in the absence of Brefeldin A. At the time points indicated, cells were fixed and stained with anti-IFNg. Data (mean ±
SD) are representative of four independent experiments.
(C) Kinetics of CD154 expression by CD44hiCD62L CD4+ T cells ex vivo. CD4+CD44hiCD62LB220 T cells from BM (circles) or spleen (diamonds) from C57BL/6
mice were isolated and stimulated with plate-bound anti-CD3 in the presence of Brefeldin A. At the time points indicated, cells were fixed and stained with
anti-CD154. Data (mean ± SD) are representative of two independent experiments.time periods (Homann et al., 2001; MacLeod et al., 2006).
However, in case of adjuvants like LPS or Monophosphoryl lipid
A, numbers of memory phenotype CD4+ T cells in spleen or LN
substantially decrease already 1 week after immunization
(Mata-Haro et al., 2007). Here we have analyzed the immune
responses of DO11.10 and OTII T helper cells to ovalbumin,
with LPS as adjuvant, of Smarta T helper cells to LCMV-derived
peptide, with LPS as adjuvant, and of wild-type T helper cells to
KLH, with CFA. In all these immune responses, more than 80% of
the surviving antigen-specific T helper cells translocate to the
BM within 3 to 8 weeks after initiation of the immune response,
demonstrating that BM is not just another site of location of
memory CD4+ T cells but the primordial site. These 80% refer
to about 20% of the CD44hiCD62L CD4+ T cells generated at
the peak of the response on day 4 in spleen and LN. The recruit-
ment of approximately 20% of the cells generated in an immune
reaction to the memory phase is remarkably similar to the recruit-
ment of 10%–20% of plasmablasts generated in acute immune
reactions to the compartment of long-lived memory plasma cells
(Radbruch et al., 2006).
Immigration of memory T helper cells into the BM is dependent
on integrin a2, as we have shown here, by blocking immigration
with integrin a2-specific antibodies in vivo. Integrin a2b1 (also
known as VLA-2) binds with high affinity to collagen type I
(Kern et al., 1993), which is one of the major collagen types
and the dominant collagen of bone and skin. Expression of integ-
rin a2 on CD4+ T cells had been described to correlate with the
capability to reexpress effector cytokines (Kassiotis et al.,
2006). Not only do memory T helper cells of distinct immune
responses depend on integrin a2 for their translocation to BM,
but memory CD4+ T cells from BM can relocate to BM, by means
of integrin a2. We could show this by adoptive transfer of
CD44hiCD62L T helper cells from BM. Within 1 day after trans-
fer, 4% of CD44hiCD62L CD4+ T cells from BM, 70% of which
express integrin a2, did home to BM, in an integrin a2-dependent
way, less than 1% to the spleen, LN, or blood. Interestingly, less
than 1% of splenic CD44hiCD62L CD4+ T cells, 10% of which
express integrin a2, homed to BM, spleen, LN, or blood. Neither
did splenic naive CD4+ T cells, not expressing integrin a2, nor
in vitro-generated effector CD4+ T cells, home preferentially toBM. It remains to be shown whether apart from the adhesion
molecule integrin a2, chemokine attraction is required to lure
memory T helper cells into the BM. The induction of integrin a2
expression, by signals so far not defined, is thus apparently a crit-
ical step in the development of a stable T helper memory
compartment in the BM.
Phenotypic and functional analysis of splenic CD44hiCD62L
CD4+ T cells has indicated a considerable heterogeneity (Stock-
inger et al., 2006). The present analysis shows that memory
T helper cells generated in defined immune reactions persist in
BM and express two distinct markers, integrin a2 (as discussed
above) and Ly-6C, at high amounts. Thus, in mice, Ly-6C is
a marker of memory T helper cells and discriminates them
from other CD44hiCD62L T helper cells of unknown etiology
and function. In BM, all CD44hiCD62L T helper cells express
Ly-6C, 40% at high amounts and 60% at intermediate amounts.
In the spleen, less than 5% of the CD44hiCD62L T helper cells
express Ly-6C. More than 80% of all Ly-6C-expressing
CD44hiCD62L T helper cells counted in the tissues analyzed
are in the BM, less than 20% in all of the other organs. We cannot
rule out yet that additional alternative homing sites for
Ly-6ChiCD44hiCD62L CD4+ T cells exist, e.g., in skin or intes-
tine, although few cells generated in the immune responses
analyzed here enhanced the skin-homing molecule CLA or the
gut-homing molecules integrin a4b7.
The role of peripheral CD4+ T cells expressing CD44hiCD62L,
i.e., the classical memory-phenotype murine CD4+ T cells, will
have to be redefined. Moreover, central memory T cells express-
ing CCR7 and CD62L were not found in the BM. The mecha-
nisms of maintenance of these cells, which are even more abun-
dant in humans than in mice, remain to be clarified as well.
In functional terms, memory CD4+ T cells from BM are efficient
helper cells. They efficiently induce antibody affinity maturation
of B cells activated by the same antigen. These immune reac-
tions apparently take place in secondary lymphoid organs,
implying that the memory T helper cells have to be reactivated
and mobilized from the BM, presumably by surveilling antigen-
presenting cells. Our analysis shows that BM memory T helper
cells are reactive to antigen substantially faster than other
T helper cells, although in terms of gene expression andImmunity 30, 721–730, May 22, 2009 ª2009 Elsevier Inc. 727
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cells reside and rest in the BM until they are reactivated by
surveilling antigen-presenting cells, is in contrast to previous
concepts assuming that memory CD4+ T cells constantly them-
selves circulate the body for surveillance of cells presenting the
appropriate antigen (Dutton et al., 1998).
The apparent molecular rationale for memory CD4+ T cells to
home to BM is their quest for IL-7. In BM, CD44hiCD62L
CD4+ T cells are located next to IL-7-expressing stroma cells.
They are resting in terms of both proliferation and gene expres-
sion, as compared to CD44hiCD62L CD4+ T cells from other
organs. IL-7 has been reported to be required for survival of
T cells and upregulation of Bcl-2 expression, in the absence of
proliferation (Kondrack et al., 2003). It also has been reported
that IL-7 mediates the transition of effector into memory CD4+
T cells (Kondrack et al., 2003; Li et al., 2003), an event that in light
of the present results takes place in the BM. In the immune
response to ovalbumin analyzed here, the specific CD4+CD44hi
T cells translocate to BM between days 6 and 21 of the response,
and the transition of ovalbumin-specific effector T cells gener-
ated in the spleen and LN to professional memory T cells could
well have happened in the BM. We could not detect a colocaliza-
tion of CD44hiCD62L CD4+ T cells with MHC class II-expressing
cells in BM (data not shown), arguing against tonic TCR stimula-
tion of memory T cells there and the induction of homeostatic
proliferation in a TCR-dependent way (Seddon et al., 2003),
a finding in accordance with the low overall proliferation rate
we observe here. Our data suggest that homeostatic prolifera-
tion may play little if any role in the maintenance of CD4+ T cell
memory, as compared to the survival signal provided by IL-7 in
the BM.
The observation described here, namely that professional
memory CD4+ T cells in the mouse express integrin a2 and
Ly-6C and persist in BM as resting cells, until they are reacti-
vated by appropriate antigen-presenting cells, adds a new
dimension to immunological memory. Reactive memory to
vaccines and pathogens can now be evaluated as resting versus
mobilized memory, the latter being the one that had been
addressed by research so far. The rules governing settling and
mobilization of CD4+ T cell memory have to be (re)investigated,
as well as the concepts of homeostatic proliferation versus
IL-7-mediated survival. Furthermore, markers of true memory
T helper cells, like murine integrin a2 and Ly-6C, may serve as
molecular targets to interfere with the persistence of pathogenic
T cell memory (Chatenoud, 2003; Taylor, 2003).
EXPERIMENTAL PROCEDURES
Mice
All mice were bred and maintained under SPF conditions at the ‘‘Bundesinsti-
tut fu¨r Risikobewertung’’ (BfR, Berlin, Germany), and experiments were per-
formed according to institutional guidelines and German Federal laws on
animal protection. Mice were used at 12–16 weeks of age. For immunization,
mice were injected i.p. with 100 mg of KLH, ovalbumin (Sigma), NP23-KLH
(Biosearch Technologies), ovalbumin323-339 peptide (R. Volkmer-Engert, Hum-
boldt University of Berlin, Berlin, Germany), or LCMV GP61-80 peptide (synthe-
sized by Neosystems) with CFA (Sigma), LPS (Invivogen), or PBS. For in vivo
blocking, mice were injected i.p. with 100 mg of the Fab fragment of integrin
a2 antibody or isotype control at day 4, 5, and 6 after immunization. To discrim-
inate between cells resident in BM versus those in blood of BM, blood was728 Immunity 30, 721–730, May 22, 2009 ª2009 Elsevier Inc.removed from BM by perfusion with PBS via the right ventricle of the heart
(Bertolino et al., 2005).
Flow Cytometry and Sorting
Single-cell suspensions were prepared from spleen, mLN, pLN, PP, BM,
thymus, and blood of individual mice, and liver were perfused, minced, and
incubated for 30 min in culture media containing 1 mg/ml collagenase type I
(Worthington) and 0.1% DNase I (Roche). Viability of cells was assessed by
trypan blue exclusion. Leukocytes were counted in a defined volume of blood
by using Tu¨rk’s solution (Merck) and total blood volume was calculated from
body weight, assuming that mice contain 72 ml blood per kg body weight
(Diehl et al., 2001). The frequencies of CD4+ lymphocytes among CD45+
leukocytes were then determined by flow cytometry, and their absolute
numbers per mouse were calculated with respect to the total blood volume
of that mouse. For cell staining, cells were preincubated in a 0.1% BSA-PBS
solution of 10 mg/ml anti-FcgRII/III (2.4G2) (BD PharMingen) for 10 min at
4C. The cells were then stained for 20 min at 4C with anti-CD4 (GK1.5),
anti-CD8 (53-6.7), anti-B220 (RA3.6B2), anti-CD25 (PC61.5), anti-CD44
(IM7), anti-CD62L (MEL14), anti-CD19 (1D3), anti-CD28 (37.51), anti-CD3
(2C11), anti-ovalbumin-specific TCR (KJ1.26), anti-NK1.1 (PK136), anti-IL-7Ra
(A7R34), anti-CD90.1 (OX-7), anti-CXCR4 (2B11), integrin a4 (R1-2), anti-
Ly-6C (AL-21), anti-CD45RB (16A), anti-CXCR5 (2G8), anti-TCRb (H57.597),
anti-CD24 (M1/69), anti-CD119 (GR20), TCR Vb Screening Panel, PerCP/
APC-Cy7-streptavidin (BD PharMingen), anti-CD197 (CCR7, 4B12), anti-
CD93 (AA4.1), anti-CD122 (5H4), anti-Ly108 (13G3-19D) (eBioscience), anti-
integrin a2 (Sam.G4) (emfret Analytics), anti-CD186 (CXCR6, 221002) (R&D
Systems), anti-CD192 (CCR2, E68) (Abcam), biotin-PNA (Vector Laboratories),
Alexa Fluor 488-streptavidin (Invitrogen), and Cy5-streptavidin (Jackson Im-
munoresearch). To exclude dead cells, we stained 1 mg/ml propidium iodide
(PI, Sigma) or 0.4 mM 40,6-diamino-2-phenylindole (DAPI, Roche). For cell sort-
ing, a BD FACSAria cell sorter (BD Biosciences) was used. For intracellular
staining, sorted cells were stimulated with 10 mg/ml CD3 antibody in presence
of Brefeldin A (5 mg/ml; Sigma) for 5 hr, or in case of analyzing kinetics of IFN-g
expression, in absence of Brefeldin A. Cells were washed, fixed with 2% form-
aldehyde (Sigma) in PBS for 15 min at room temperature, and stained with anti-
IL-2 (S4B6), anti-TNF-a (MP6-XT22), anti-IFN-g (XMG1.2), anti-IL-10 (JES5-
16E3), anti-IL-17 (TC11-18H10), anti-IL-4 (11B11) (BD Biosciences), and
anti-CD154 (MR1) (Miltenyi Biotec) as described (Lo¨hning et al., 2003). Stained
samples were analyzed in a BD LSR II flow cytometer (BD Biosciences). Flow
cytometric data were analyzed with FlowJo (Tree Star, Inc.) software.
Detection of Antigen-Specific CD4+ T Cells
We detected antigen-specific CD4+ T cells according to CD154 expression
(Frentsch et al., 2005). Cells from spleen and BM of KLH-immunized mice
were stimulated in medium with 10 mg/ml KLH for 6 hr. We added Brefeldin
A (5 mg/ml) for the last 4 hr of stimulation. After staining with antibodies against
CD4, CD44, and B220 and fixation with 2% formaldehyde, we permeabilized
the cells with 0.5% saponin (Sigma) in 0.5% BSA/PBS and stained intracellular
IFN-g and CD154.
Cell Labeling and Adoptive Transfer
For adoptive transfer, CD44hiCD62L CD4+ T, naive CD44loCD62L+ CD4+ T,
and naive B cells from C57BL/6, Thy1.1-LCMV-TCR Tg (Smarta), or oval-
bumin-TCR Tg (DO11.10 or OTII) mice were sorted with MACS (Miltenyi Bio-
tec) and FACSAria as CD4+CD62LCD25B220, CD4+CD44loCD25B220,
and CD4CD138CD19+ cells, respectively. For positive selection and anti-
body blocking, we used anti-CD4 Fab fragment, anti-CD19 Fab fragment,
anti-integrin a2 Fab fragment, anti-Ly-6C Fab fragment, and streptavidin-
MACS beads (Miltenyi Biotec). We transferred 1 3 105 to 5 3 106 cells i.v.
into C57BL/6, Ly5.1-C57BL/6, Balb/c-scid, or RAG1-deficient mice, as indi-
cated. To monitor transferred cells in host mice, cells were labeled before
transfer with 1 mM of Carboxyfluorescein diacetate succinimidyl ester
(CFSE, Invitrogen) in PBS at room temperature for 3 min or with PKH-26
(Sigma) according to the manufacturer’s manual.
Enzyme-Linked Immunosorbent Assay
Serum samples were collected after NP23-KLH immunization and NP-
specific antibodies were measured by using plastic surfaces coated with
Immunity
Memory CD4+ T Cells Reside in Bone MarrowNP3- or NP24-BSA (Biosearch Technologies). Hapten-specific antibodies were
detected with alkaline phosphatase-conjugated antibodies to mouse IgG1 and
IgM (Southern Biotechnology).
Cell Cycle, BrdU Incorporation, Cell Division, andApoptosis Analysis
For cell cycle analysis, 2–43 106 cells were washed twice in PBS and fixed in
ice-cold 70% ethanol at 4C overnight. After washing, cells were treated with
100 U/ml of RNase A in PBS at 37C for 30 min and incubated in PI (50 mg/ml in
PBS) for 30 min at room temperature. For in vivo proliferation, mice were in-
jected i.p. with 1 mg of BrdU four times over 48 hr. Cells from BM, spleen,
mLN, and blood were harvested 12 hr after the last injection. BrdU staining
of CD4+ T cells was analyzed by flow cytometry according to manufacturer’s
specification (BD PharMingen). For analysis of proliferation, sorted
CD44hiCD62L CD4+ T cells were incubated with 1 mM CFSE, then washed
thoroughly with 10% FCS-RPMI and stimulated with plate-bound anti-CD3
(2C11, 10 mg/ml) at 37C in a CO2 incubator for 3 days before cytometric anal-
ysis. For enumeration of apoptotic cells, sorted CD44hiCD62L CD4+ T cells
from BM and spleen were stimulated with plate-bound anti-CD3 for 24 hr
and then stained with AnnexinV (BD PharMingen) and PI according to the
manufacturer’s protocol.
GeneChip Hybridization of Microarrays and Data Analysis
Total RNA from CD44hiCD62LCD25B220 CD4+ T cells isolated from
spleen or BM of C57BL/6 mice was prepared with QIAGEN RNeasy Mini kit
(QIAGEN). All experiments were repeated three times with individually sorted
cells purified to more than 96% homogeneity. DNA microarray analysis of
gene expression was performed at the gene array facility in the DRFZ. Hybrid-
ization was done in a hybridization oven 640 (Affymetrix). Washing and staining
of the MOE-430 2.0 chips were done in the Fluidics Station 400 (Affymetrix).
Fluorescent images of hybridized microarrays were obtained with an Affyme-
trix GeneChip Scanner 3000. All relevant microarray data of the GCOS soft-
ware (Affymetrix) were imported into the Bioretis database (http://www.
bioretis-analysis.de/). All data are publicly available in the Bioretis and GEO
databases. The total list of 1756 differentially regulated genes was obtained
by combining the two lists with default parameters for increased and
decreased expression. These parameters combine a threshold for gene
expression, Present and Marginal detection and Decrease or Increase change
calls (i.e., >50%, hereR5 of all 9 calls in either D or I direction) or a very strin-
gent t test p value (i.e., Bonferroni corrected; e.g., p value for this data set was
%5.279E-08) for 9 versus 12 logged fold change values, all data obtained
during chip versus chip comparison or absolute analysis with GCOS software.
The unpublished exact filter parameters of high-performance chip data
analysis (HPCDA) can be found on the Bioretis website (http://www.
bioretis-analysis.de/, click login in the public content, choose ‘‘view single
results’’ and then one data set, choose an existing parameter set and see
each default parameter; e.g., all 3 versus 3 chips analyses with Affymetrix Latin
Square data set are referred to as SGU; database description and a compar-
ison with RMA/SAM or dChip) (Menssen et al., 2009). For hierarchical cluster
analysis, we used the program Genes@Work (Califano et al., 2000) with
gene vectors as normalization, Pearson correlation with mean as similarity
measure, and center of mass.
Generation of Effector CD4+ T Cells
Naive CD4+ T cells from DO11.10 Tg mice were isolated as described previ-
ously (Lo¨hning et al., 2003). Irradiated (30 Gy) Balb/c splenocytes were used
as antigen-presenting cells at a ratio of 5:1. The ovalbumin323-339 peptide
was added at 0.5 mM. For Th1 differentiation, cells were stimulated in the pres-
ence of 5 ng/ml recombinant murine IL-12 (R&D Systems) and 5 mg/ml anti-
IL-4. For Th2 differentiation, cells were stimulated in the presence of murine
IL-4 (100 ng/ml, culture supernatant of HEK293T cells transfected with an
expression plasmid, encoding murine IL-4), 5 mg/ml anti-IL-12 (C17.8.6), and
anti-IFN-g. Dead cells were removed by Ficoll-Hypaque separation.
Immunofluorescent Staining and Confocal Microscopy
For staining, histological samples were fixed in 4% paraformaldehyde and
equilibrated in 30% sucrose/PBS (Tokoyoda et al., 2004). Cryostat sections
of adult femurs were stained and mounted with Fluorescent Mounting Medium
(DakoCytomation). All confocal microscopy was carried out on a DM IRE2(Leica). Monoclonal antibodies against VCAM-1 (429), B220, F4/80 (A3-1),
Gr-1 (RB6-8C5), CD11c (HL3), and Thy1.1 (HIS51) (BD PharMingen) and a poly-
clonal antibody against IL-7 (Genzyme) were used. For secondary antibodies,
Cy3 or Cy5 donkey anti-goat IgG and Cy3 donkey anti-rat IgG were purchased
from Jackson Laboratories.
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